GULF RESOURCES, INC. quarterly report, Q3 FY2022

Gulf Resources, Inc. — Q3 2022 Form 10-Q

Reporting period: Three and nine months ended September 30, 2022. The unaudited consolidated statements cover Gulf Resources and its China-based subsidiaries. The company produces and trades bromine and crude salt; its chemical-products plants remain closed, and its natural-gas project is subject to approvals.

Financial performance

MetricQ3 2022Q3 2021Nine months 2022Nine months 2021
Revenue$22.86 million$17.75 million$47.51 million$34.16 million
Gross profit$14.46 million$9.56 million$26.45 million$14.87 million
Gross margin63%54%56%44%
Operating income$11.94 million$7.10 million$16.99 million$1.43 million
Net income$8.97 million$5.39 million$12.75 million$0.19 million
Diluted EPS$0.86$0.52$1.22$0.02
Operating cash flowNot separately providedNot separately provided$37.10 million$11.06 million
  • Q3 revenue rose 29%; higher bromine sales drove most of the increase. Bromine revenue was $19.85 million, up 33%, reflecting 6% higher volume and a reported 26% increase in average selling price. Crude-salt revenue increased 3% to $2.93 million.
  • For the nine months, revenue rose 39%. Bromine revenue increased 41% to $41.87 million, and crude-salt revenue increased 25% to $5.51 million. Management attributed growth principally to higher selling prices and quantities.
  • YTD gross margin improved to 56% from 44%. Operating income also benefited from lower general and administrative expenses, including the absence of approximately $3.1 million of stock-grant expense recorded in Q2 2021.
  • Foreign-currency translation was a significant offset to reported comprehensive results: translation losses were $15.93 million in Q3 and $30.77 million for the nine months, leaving comprehensive losses of $6.96 million and $18.03 million, respectively, despite net income.

Financial position and liquidity

  • At September 30, 2022, cash was $92.64 million, down from $95.77 million at December 31, 2021. Total assets were $290.54 million; total liabilities were $21.93 million; stockholders’ equity was $268.61 million.
  • Current assets of $107.16 million compared with current liabilities of $13.05 million. The company reported no conventional bank borrowings in the presented balance sheet. Lease liabilities totaled $9.49 million: $1.62 million finance leases and $7.88 million operating leases.
  • YTD operating cash flow of $37.10 million was largely offset by $33.22 million of capital spending, $0.28 million of finance-lease repayments, and $6.73 million of adverse exchange-rate effects on cash. Cash decreased by $3.13 million overall.
  • Accounts receivable declined to $10.00 million from $14.53 million at year-end; all September 30 receivables were aged 60 days or less. Inventory was $0.60 million.
  • Management said available funds and operating cash flows should cover anticipated operating needs and obligations for the next 12 months. Cash is held with PRC financial institutions and is not insured or otherwise protected, according to the filing.

Outlook, operating developments, and risks

  • Bromine operations and approvals: The company says four bromine factories resumed in February 2022. It received an oral government notification permitting Factory No. 8 to resume in August and expected it to generate revenue in Q4 2022. Factories No. 2 and No. 10 still awaited approval; possible well or aqueduct modifications may be required. Bromine-facility closures and inspections have disrupted production.
  • Chemical business: Chemical-products revenue remained zero because the plants have been closed since 2017 and are being relocated to a new industrial park. Construction and equipment installation have been delayed by COVID-related restrictions, supply-chain issues, electricity restrictions, and permitting. Management could not estimate completion or production start dates. Estimated total relocation cost is approximately $69 million; $45.58 million had been recorded in prepaid land leases and property, plant and equipment. Capital-expenditure commitments were $17.67 million.
  • Natural gas: Trial production at the Sichuan well was halted in 2019 pending project, safety, environmental, land, exploration, and mining approvals. The segment reported $0.13 million of YTD revenue, but the filing does not clearly explain the source of that revenue or indicate commercial production had resumed.
  • Concentration: The top five customers represented 52.9% of nine-month sales. The top five suppliers provided all raw materials purchased in the period.
  • Land-use contingency: Administrative decisions and court rulings concerning land used by bromine factories ordered return of land, restoration or demolition/confiscation of facilities, and aggregate penalties of about RMB 1.3 million ($184,000). The company says enforcement is remote and recorded no accrual, but acknowledges further action could cause liabilities, penalties, or operational disruption. It also reports that it lacks ownership certificates for certain buildings and salt pans with a $14.94 million carrying value.
  • Other items: On October 7, 2022, after quarter-end, the company issued 200,000 shares to executive officers, directors, staff, and a consultant under its equity incentive plan. Shares outstanding were 10,671,924 as of November 14, 2022, versus 10,471,924 at September 30. The company does not anticipate cash dividends in the foreseeable future. Management reported disclosure controls were effective and no material quarterly change in internal control over financial reporting.

Most important facts for investors to verify

  1. Whether Factory No. 8 actually resumed production and generated Q4 revenue, and the status of approvals for Factories No. 2 and No. 10.
  2. The revised schedule, remaining funding needs, and permitting status for the chemical-factory relocation and the Sichuan natural-gas project.
  3. Whether bromine pricing and margins are sustainable, given the strong contribution of higher selling prices to 2022 earnings.
  4. Progress and potential consequences of the land-use proceedings, including the risk of enforcement or operating disruption.
  5. Cash availability and foreign-exchange exposure: most cash is held in PRC institutions, and currency translation materially reduced comprehensive results and reported cash.
  6. Customer and supplier concentration, and the dilution effect of the 200,000 post-quarter share issuance.
  7. The filing contains some inconsistent narrative wording about income versus loss and comparative periods; verify reported results against the financial statements and segment tables.